Dorsal Root Ganglion Stimulation Is Paresthesia-Independent: A Retrospective Study.


Journal

Neuromodulation : journal of the International Neuromodulation Society
ISSN: 1525-1403
Titre abrégé: Neuromodulation
Pays: United States
ID NLM: 9804159

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 02 08 2018
revised: 20 11 2018
accepted: 04 12 2018
pubmed: 1 2 2019
medline: 2 6 2020
entrez: 1 2 2019
Statut: ppublish

Résumé

Neuromodulation is an important tool for achieving pain relief in otherwise-intractable neuropathic pain conditions. Dorsal root ganglion (DRG) stimulation, in which primary sensory neurons are stimulated prior to their entry into the spinal canal, provides treatment with high levels of dermatomal specificity and can provide advantages compared to conventional spinal cord stimulation. Although DRG stimulation can produce perceptible paresthesias, many patients operate their systems at subthreshold amplitudes that do not elicit this sensation. Pain relief both with and without paresthesia was investigated in this retrospective analysis. A retrospective review of all qualifying permanent DRG stimulation systems at a single center over more than a three-year period was completed. Pain (0-10 numeric rating scale) was assessed at baseline, at the end of the trial, and after three, six, and twelve months of treatment. Patients were categorized based on their usage of the stimulator at amplitudes that either did or did not produce paresthesias. Of the 39 patients, 34 (87%) reported having no-paresthesias at any of the follow-up visits. Average pain relief was 73.9% after the trial period and 63.1% after 12 months of treatment. The responder rate (50% or better pain relief) after three months of treatment was more than 80%. Exploratory subgroup analyses showed that similar degrees of pain relief were achieved in numerous body regions and with various pain etiologies. The five patients who reported paresthesias during treatment had pain relief similar to those of the group that did not experience paresthesias. Clinically significant and sustained pain relief over more than a period of 12 months was achieved with DRG stimulation programmed at amplitudes below the perceptual level. Thus, the reported analgesia was paresthesia-independent. That good clinical outcomes were observed independent of the generation of paresthesia in DRG stimulation suggests several mechanisms of action, including the inhibition of supraspinal regions involved in somatic paresthesia sensation. The retrospective results presented here posit that future prospective study of DRG stimulation delivered at below the threshold of perceptible paresthesias is warranted.

Identifiants

pubmed: 30701632
doi: 10.1111/ner.12921
pii: S0002-8223(21)07037-1
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

937-942

Informations de copyright

© 2019 International Neuromodulation Society.

Références

Gildenberg PL. History of electrical neuromodulation for chronic pain. Pain Med 2006;7:S7-S13.
Van Buyten JP, Smet I, Liem L, Russo M, Huygen F. Stimulation of dorsal root ganglia for the management of complex regional pain syndrome: a prospective case series. Pain Pract 2015;15:208-216.
Deer TR, Grigsby E, Weiner RL, Wilcosky B, Kramer JM. A prospective study of dorsal root ganglion stimulation for the relief of chronic pain. Neuromodulation 2013;16:67-72.
Liem L, Russo M, Huygen FJPM et al. One-year outcomes of spinal cord stimulation of the dorsal root ganglion in the treatment of chronic neuropathic pain. Neuromodulation 2015;18:41-48.
Deer TR, Levy RM, Kramer J et al. Dorsal root ganglion stimulation yielded higher treatment success rate for CRPS and causalgia at 3 and 12 months: randomized comparative trial. Pain 2017;158:669-681.
Liem L, Russo M, Huygen FJPM et al. A multicenter, prospective trial to assess the safety and performance of the spinal modulation dorsal root ganglia neurostimulator system in the treatment of chronic pain. Neuromodulation 2013;16:471-482.
Krames ES. The role of the dorsal root ganglion in the development of neuropathic pain. Pain Med 2014;15:1669-1685.
Koopmeiners AS, Mueller S, Kramer J, Hogan QH. Effect of electrical field stimulation on dorsal root ganglion neuronal function. Neuromodulation 2013;16:304-311.
van Bussel CM, Stronks DL, Huygen FJPM. Successful treatment of intractable complex regional pain syndrome type I of the knee with dorsal root ganglion stimulation: a case report. Neuromodulation 2015;18:58-60.
Verrills P, Mitchell B, Vivian D, Cusack WF, Kramer J. Subthreshold stimulation of the dorsal root ganglia: retrospective study. Paper presented at: North American Neuromodulation Society (NANS), 2017; Las Vegas, NV
Deer TR, Levy RM. Paresthesia versus paresthesia-free dorsal root ganglion stimulation: an ACCURATE sub-analysis. Manuscript in preparation.
Courtney P, Espinet A, Mitchell B et al. Improved pain relief with burst spinal cord stimulation for two weeks in patients using tonic stimulation: results from a small clinical study. Neuromodulation 2015;18:361-365.
Crosby ND, Goodman Keiser MD, Smith JR, Zeeman ME, Winkelstein BA. Stimulation parameters define the effectiveness of burst spinal cord stimulation in a rat model of neuropathic pain. Neuromodulation 2014;18:1-8.
Kapural L, Yu C, Doust MW et al. Novel 10-kHz high-frequency therapy (HF10 therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain. Anesthesiology 2015;123:851-860.
Dworkin RH, Turk DC, Wyrwich KW et al. Interpreting the clinical importance of treatment outcomes in chronic pain clincial trials: IMMPACT recommendations. J Pain 2008;9:105-121.
Lauridsen HH, Hartvigsen J, Manniche C, Korsholm L, Grunnet-Nilsson N. Responsiveness and minimal clinically important difference for pain and disability instruments in low back pain patients. BMC Musculoskelet Disord 2006;7:82-98.
Paul AR, Kumar V, Roth S, Gooch MR, Piltsis JG. Establishing minimal clinically important difference of spinal cord stimulation therapy in post-laminectomy syndrome. Neurosurgery 2017;81:1011-1015.
de Vos CC, Bom MJ, Vanneste S, Lenders MWPM, de Ridder D. Burst spinal cord stimulation evaluated in patients with failed back surgery syndrome and painful diabetic neuropathy. Neuromodulation 2013;17:152-159.
North RB, Ewend MG, Lawton MT, Piantadosi S. Spinal cord stimulation for chronic, intractable pain: superiority of "multi-channel" devices. Pain 1991;44:119-130.
Wolter T, Kiemen A, Porzelius C, Kaube H. Effects of sub-perception threshold spinal cord stimulation in neuropathic pain: a randomized controlled double-blind crossover study. Eur J Pain 2012;16:648-655.
Deer TR, Pope JE, Lamer TJ, et al. The Neuromodulation Appropriateness Consensus Committee on best practices for dorsal root ganglion stimulation. Neuromodulation 2019;22:1-35.
Mekhail NA, Levy RM, Deer TR, et al. Comparison of evoked paresthesia between SCS and DRG stimulation: an ACCURATE sub-study. Paper presented at: North American Neuromodulation Society (NANS), 2017; Las Vegas, NV.
Deer TR, Levy RM, Kramer J, et al. Paresthesia versus paresthesia-free dorsal root ganglion stimulation: an ACCURATE sub-analysis. Paper presented at: North American Neuromodulation Society (NANS), 2017; Las Vegas, NV.
Kramer J, Foster A, Kent AR, Cusack W. Fundamentals and mechanisms of dorsal root ganglion stimulation. In: Krames ES, Peckham PH, Rezai AR, editors. Neuromodulation: comprehensive textbook of principles, technologies, and therapies. Volume 1. London: Elsevier, 2018.
Buonocore M. Neurophysiological responses for better understanding the antalgic mechanisms of spinal cord stimulation. Pain & Relief 2013;2:1000118.
Arle JE, Mei L, Carlson KW, Shils JL. High-frequency stimulation of dorsal column axons: Potential underlying mechanism of paresthesia-free neuropathic pain relief. Neuromodulation 2016;19:385-397.
Blankenburg F, Taskin B, Ruben J et al. Imperceptible stimuli and sensory processing impediment. Science 2003;299:1864.
Kajander KC, Wakisaka S, Bennett GJ. Spontaneous discharge originates in the dorsal root ganglion at the onset of a painful peripheral neuropathy in the rat. Neurosci Lett 1992;138:225-228.
Amir R, Michaelis M, Devor M. Membrane potential oscillations in dorsal root ganglion neurons: Role in normal electrogenesis and neuropathic pain. J Neurosci 1999;19:8589-8596.
Kent AR, Min X, Hogan QH, Kramer JM. Mechanisms of dorsal root ganglion stimulation in pain suppression: A computational modeling analysis. Neuromodulation 2018;21:234-246.

Auteurs

Paul Verrills (P)

Metro Pain Group, Melbourne, VIC, Australia.

Bruce Mitchell (B)

Metro Pain Group, Melbourne, VIC, Australia.

David Vivian (D)

Metro Pain Group, Melbourne, VIC, Australia.

William Cusack (W)

Abbott Laboratories, Sunnyvale, CA, USA.

Jeffery Kramer (J)

Abbott Laboratories, Sunnyvale, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH